About this product
Product Overview
Tobra-D Eye Drop 5Ml is an antibiotic ear/eye drop with a local anaesthetic, containing Tobramycin & Dexamethasone, Ear. It is available as an eye preparation and is commonly used for treating infection and relieving pain in the ear or eye. For the best results, use it as part of the treatment plan advised by your doctor.
Uses of
Tobra-D Eye Drop 5Ml
Tobra-D Eye Drop 5Ml is mainly prescribed for treating infection and relieving pain in the ear or eye. Your doctor may also recommend it for related conditions, but you should use it only for the purpose it was prescribed.
Key Benefits
Used correctly, it clears infection while relieving pain.
Active Ingredients
The active ingredient is Tobramycin & Dexamethasone, Ear. It combines an antibiotic with a local anaesthetic. This targeted action is what makes it effective for its approved uses.
Recommended Dosage
Always use it exactly as your doctor prescribes. The right amount depends on your age, condition and response, so never increase, reduce or stop it on your own. If you are unsure, check the leaflet or ask your pharmacist.
Side Effects
Like all medicines, it may cause side effects in some people, such as brief stinging or irritation at the site. These are often mild and settle on their own, but seek medical advice if any are severe or persistent.
Warnings and Precautions
Use as directed; do not share; complete the course. Tell your doctor about your full medical history, allergies and any other medicines or supplements you take. Use only if your doctor advises.
Storage Instructions
Store as directed and keep the bottle closed. Discard within four weeks of opening unless told otherwise. Always keep it out of the reach of children and do not use it after the expiry date.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
Customer reviews
You must be logged in to post a review.
Reviews
Clear filtersThere are no reviews yet.